Synonyms: Taigexyn® | TG-873870 | TG873870
nemonoxacin is an approved drug (Taiwan (2014))
Compound class:
Synthetic organic
Comment: Nemonoxacin is a non-fluorinated quinolone antibacterial with broad-spectrum activity against Gram-positive and Gram-negative bacteria and atypical pathogens, including methicillin-resistant S. aureus (MRSA) and vancomycin-resistant pathogens [1-2]. It selectively inhibits bacterial DNA topoisomerase (DNA gyrase) activity.
|
|
References |
1. Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR. (2009)
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. J Antimicrob Chemother, 64 (6): 1226-9. [PMID:19833635] |
2. Chotikanatis K, Kohlhoff SA, Hammerschlag MR. (2014)
In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother, 58 (3): 1800-1. [PMID:24366753] |
3. Lauderdale TL, Shiau YR, Lai JF, Chen HC, King CH. (2010)
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates. Antimicrob Agents Chemother, 54 (3): 1338-42. [PMID:20065058] |
4. Poole RM. (2014)
Nemonoxacin: first global approval. Drugs, 74 (12): 1445-53. [PMID:25079302] |